SEC Form 4 · accession 0001127602-18-032631
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas C Zielinski
Officer — EVP & General Counsel
Period of report
Nov 7, 2018
Accepted (ET)
Nov 9, 2018 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 7, 2018 | M | 3,382 | $131.80 | A | 29,466 | D | |
| Common Stock | Nov 7, 2018 | M | 2,552 | $166.97 | A | 32,018 | D | |
| Common Stock | Nov 7, 2018 | M | 1,892 | $232.04 | A | 33,910 | D | |
| Common StockF1 | Nov 7, 2018 | S | 7,826 | $289.71 | D | 26,084 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $131.80 | Nov 7, 2018 | M | 3,382 | D | — | Mar 1, 2026 | Common Stock | 3,382 | 3,382 | D |
| Employee Stock Option (Right to Buy)F3 | $166.97 | Nov 7, 2018 | M | 2,552 | D | — | Mar 1, 2027 | Common Stock | 2,552 | 7,658 | D |
| Employee Stock Option (Right to Buy)F4 | $232.04 | Nov 7, 2018 | M | 1,892 | D | — | Mar 1, 2028 | Common Stock | 1,892 | 9,462 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $289.69 to $289.84. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2The option represents a right to purchase a total of 20,289 shares, and is exercisable in six semi-annual installments, with three installments of 3,381 shares each and three installments of 3,382 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date.
- F3The option represents a right to purchase a total of 15,314 shares, and is exercisable in six semi-annual installments, with four installments of 2,552 shares each and two installments of 2,553 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.
- F4The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.